(Nasdaq: VITL) • August 2025 Corporate Presentation Vital Farms, Inc. Reporting Disclaimer This presentation contains, in addition to historical information, certain "forward-looking statements" (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended), that are based on our current assumptions, expectations and projections about future performance and events and relate to, among other matters, our future financial perfo ...

Financial Performance - AATI per diluted common share was $181, a 56% increase year-over-year[4, 5] - Outstanding underwriting income reached $626 million, a 46% increase from the prior year quarter[4] - Net Investment Income (NII) on an APTI basis was $955 million, up 9% year-over-year[4] - The calendar year combined ratio improved by 320 bps to 893%[4, 6, 14] Capital Management - $20 billion of capital was returned to shareholders in the second quarter, including $18 billion in stock repurchases and $254 million in dividends[4] - Aggregate share repurchases totaled $90 billion, representing 17% of shares outstanding on March 31, 2024[47, 49] - The company maintained a leverage guidance between 15-20%, with a 179% total debt to total capital leverage ratio[48] Segment Performance - General Insurance TTM NPW reached $239 billion[11] - North America Commercial Lines NPW increased 4% on a comparable basis[19] - International Commercial Lines NPW increased 1% from 2Q24, driven by Casualty and Global Specialty[21, 22] - Global Personal Insurance NPW declined 3% from 2Q24, primarily due to changes in reinsurance structures in the High Net Worth business[23, 24]

Disclaimer Radar Revolution. Delivered. Q2 2025 Financial Results This Presentation contains "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, both as amended by the Private Securities Litigation Reform Act of 1995. The words "expect," "believe," "estimate," "intend," "plan," "anticipate," "may," "should," "strategy," "future," "will," "project," "potential" and similar expressions indicate forward-looking statements. Forward-looking state ...

Financial Performance - Revenue increased by 35.3% to $234.5 million in 2Q25 compared to 2Q24[12] - YTD25 revenue increased by 25.5% to $412.4 million compared to YTD24[14] - Net income improved by $28.5 million to $18.4 million in 2Q25[19] - Consolidated Adjusted EBITDA increased by 69.8% to $39.6 million in 2Q25[26] - Consolidated Adjusted EBITDA as a percentage of revenue increased by 340 bps to 16.9% in 2Q25[26] Strategic Priorities and Guidance - The company increased expected FY25 revenue range, expecting 17% growth over FY24[11] - The company increased expected Consolidated Adjusted EBITDA range, expecting 19% growth over FY24[11] - The company expects organic growth at or above 7% to 9% range in 2025[29] Segment Performance - Assessment, Permitting & Response segment revenue increased to $103.9 million in 2Q25[65] - Measurement & Analysis segment revenue increased to $62.8 million in 2Q25[68] - Remediation & Reuse segment revenue increased to $67.8 million in 2Q25[76]

Financial Performance - Total operating revenues for the three months ended June 30, 2025 were $45127 thousand, compared to $43338 thousand in 2024[7] - Net loss for the three months ended June 30, 2025 was $5487 thousand, compared to a net loss of $712 thousand in 2024[7] - Total operating expenses for the three months ended June 30, 2025 were $47482 thousand, compared to $42470 thousand in 2024[7] - For the six months ended June 30, 2025, the company's Adjusted EBITDA was $13820 thousand, compared to $16434 thousand in 2024[34] Operational Results - Renewable Natural Gas (RNG) production volumes increased by 31 MMBtu for the quarter ended June 30, 2025[8, 10] - Renewable Electricity Generation (REG) production decreased by 3 MWh for the quarter ended June 30, 2025[8] - The average realized price per RIN decreased by $070 for the quarter ended June 30, 2025[9, 10] - RINs available for sale decreased by 3549 thousand in the second quarter of 2025 compared to the second quarter of 2024[10, 15] Business Development - The Second Apex RNG Facility was commissioned in June 2025[20] - Capital investment for Montauk Ag Renewables project increased to a range of $180000 to $220000 thousand, with commercial operations expected in 2026[25] - A contract was signed to deliver 140 tons of biogenic carbon dioxide from Texas facilities under a 15-year contract with European Energy North America, with total revenues ranging from $170000 to $201000 thousand and commissioning expected in 2027[28]

Financial Performance - Net sales were $936 million, a decrease of 4.9% year-over-year[12] - Constant currency net sales decreased by 6.7% year-over-year, including a 3.2% impact from Byte[10, 14] - Adjusted EBITDA was $197 million, a 14.6% increase year-over-year, with a margin of 21.1%, up 360 bps year-over-year[12, 14] - Adjusted EPS was $0.52, a 6.6% increase year-over-year[10, 14] - Operating cash flow was $48 million, a 77% decrease year-over-year[12] Segment Performance - Essential Dental Solutions (EDS) sales were $387 million, a reported increase of 2.9% and a constant currency increase of 1.1%[17] - Orthodontic and Implant Solutions (OIS) sales were $226 million, a reported decrease of 18.1% and a constant currency decrease of 19.4%, including a ~$35 million Byte impact[17] - Connected Technology Solutions (CTS) sales were $243 million, a reported decrease of 3.8% and a constant currency decrease of 5.9%[17] - Wellspect Healthcare sales were $80 million, a reported increase of 1.2% and a constant currency decrease of 2.5%, including a ~4.5% impact from prior year U S distributor initial stocking order[17] Regional Performance - U S net sales were $293 million, a constant currency decrease of 18.3%, including a 7.7% Byte impact[10] - Europe net sales were $404 million, a constant currency decrease of 0.4%[10] - Rest of World net sales were $239 million, a constant currency increase of 0.5%[10] Outlook - The company reaffirmed its FY2025 outlook, with constant currency growth between (4.0%) and (2.0%), including a (2.0%) Byte impact[19] - The company reaffirmed its FY2025 outlook, with reported sales between $3.60 billion and $3.70 billion[19] - The company reaffirmed its FY2025 outlook, with adjusted EBITDA margin greater than 19% and adjusted EPS between $1.80 and $2.00[19]

Financial Performance - ACI's Payment Software segment revenue grew by 18% and Biller segment grew by 13% in the first half of 2025 compared to the same period last year[12] - Adjusted EBITDA for the first half of 2025 increased by 24% compared to the first half of 2024[13] - The company repurchased 2.4 million shares in Q2 2025, representing 2.4% of shares outstanding[13,24] - ACI's net adjusted EBITDA margin was 34% in the first half of 2025, up from 31% in the first half of 2024[18,24,28] - ACI had $175 million in adjusted EBITDA in the first half of 2025[18,24] - Cash flow from operating activities was $128 million in the first half of 2025[18] Financial Position - ACI's cash balance was $190 million as of June 30, 2025[18,24] - The net debt leverage ratio was 1.4x[18,24] - The company retired $400 million senior unsecured notes maturing in 2026[24] Guidance - ACI is raising its full-year outlook for both revenue and adjusted EBITDA for 2025[13,24,36] - Updated full year 2025 revenue guidance is $1710 million to $1740 million, compared to the prior guidance of $1690 million to $1720 million[23] - Updated full year 2025 adjusted EBITDA guidance is $490 million to $505 million, compared to the prior guidance of $480 million to $495 million[23]

Second Quarter 2025 Results Earnings Presentation Important Disclosures IMPORTANT NOTICES The inclusion of references to P10, Inc. ("P10" or the "Company") in this presentation is for information purposes only as the holding company of various subsidiaries. P10 does not offer investment advisory services and this presentation is neither an offer of any investment products nor an offer of advisory services by P10. By accepting this presentation, you acknowledge that P10 is not offering investment advisory se ...

Financial Performance - Q2'25 - Revenues net of pass-through costs decreased by 2% year-over-year to $736 million[16] - Adjusted EBITDA decreased by 4% year-over-year to $86 million[16] - Adjusted Unlevered Free Cash Flow was $57 million[16] - Net Leverage Ratio was 4.6x[16] Segment Performance - Branded Services revenues decreased by 8% year-over-year[39] and Adjusted EBITDA decreased by 21% year-over-year[39] - Experiential Services revenues increased by 9% year-over-year[43] and Adjusted EBITDA increased by 14% year-over-year[43] - Retailer Services revenues remained flat year-over-year[47] and Adjusted EBITDA increased by 8% year-over-year[48] Outlook and Strategy - Reaffirming 2025 guidance, anticipating revenues and Adjusted EBITDA to be down low single digits to flat versus the prior year[33] - Expect Adjusted Free Cash Flow conversion to be greater than 50% of Adjusted EBITDA[33] - Expect improved H2'25 performance and cash generation[19]

Cautionary Note Regarding Forward-Looking Statements Krispy Kreme, Inc. SECOND QUARTER 2025 EARNINGS PRESENTATION AUGUST 7, 2025 Krispy Kreme | 2Q25 Earnings 1 Certain statements made in this presentation and on the conference call that this presentation accompanies are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of forward-looking terminology, including terms such as "plan," "believe," "may," ...